SCHEMBL7450520

SCHEMBL7450520

Cc1cc(COc2ccc(N(CC(O)C(=O)NO)C(=O)C(F)(F)F)cc2)c2ccccc2n1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 15/20 0.53
MMP1 P03956 5/20 0.50
MMP3 P08254 5/20 0.50
MMP2 P08253 3/20 0.50
MMP9 P14780 3/20 0.50
ADAM33 Q9BZ11 3/20 0.50
MMP7 P09237 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
MMP14 P50281 1/20 0.49
MMP15 P51511 1/20 0.49
MMP16 P51512 1/20 0.49
ADAM10 O14672 1/20 0.49
ADAM9 Q13443 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600735 1.00 ADAM17 (0.53) ADAM17MMP1MMP3MMP2MMP9
SCHEMBL6597686 1.00 ADAM17 (0.53) ADAM17MMP1MMP3MMP2MMP9
SCHEMBL6597457 0.83 ADAM17 (0.57) ADAM17MMP2MMP9MMP13
SCHEMBL7404184 0.83 ADAM17 (0.57) ADAM17MMP2MMP9MMP13
SCHEMBL6597422 0.83 ADAM17 (0.57) ADAM17MMP2MMP9MMP13
Trifluoroacetic Acid SCHEMBL6600731 0.79 ADAM17 (0.69) ADAM17MMP1MMP3MMP2ADAM10
Trifluoroacetic Acid SCHEMBL6597682 0.79 ADAM17 (0.69) ADAM17MMP1MMP3MMP2ADAM10
SCHEMBL6598558 0.78 ADAM17 (0.53) ADAM17MMP2MMP9MMP13
SCHEMBL6597067 0.77 MMP2 (0.55) ADAM17MMP1MMP3MMP2MMP9
SCHEMBL6596662 0.77 ADAM17 (0.51) ADAM17MMP2MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed